← Scroll for more →
Kymera Therapeutics, Inc. (KYMR)
Biological Products, (No Diagnostic Substances)
Latest Price
$126.63
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
19.42
P/B Ratio
6.52
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 12.35M | $1.42B | 14.47% | +649.3K | 2026-06-30 |
| Baker Bros. Advisors LP | 8.66M | $992.0M | 10.15% | -- | 2026-06-30 |
| Avoro Capital Advisors LLC | 7.47M | $857.0M | 8.76% | -- | 2026-06-30 |
| Price T Rowe Associates Inc | 7.11M | $815.0M | 8.34% | +1.05M | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 6.26M | $717.0M | 7.33% | +792.3K | 2026-06-30 |
| BlackRock, Inc. | 5.54M | $635.0M | 6.49% | +477.3K | 2026-06-30 |
| Bvf Inc | 3.87M | $444.0M | 4.54% | -1.63M | 2026-06-30 |
| Wellington Management Group LLP | 3.68M | $421.0M | 4.31% | -214.7K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.99M | $343.0M | 3.51% | +118.1K | 2026-06-30 |
| Siren, L.L.C. | 2.94M | $336.0M | 3.44% | -251.0K | 2026-06-30 |